Literature DB >> 12138108

FCP1 phosphorylation by casein kinase 2 enhances binding to TFIIF and RNA polymerase II carboxyl-terminal domain phosphatase activity.

Benoît Palancade1, Marie-Françoise Dubois, Olivier Bensaude.   

Abstract

Dephosphorylation of RNA polymerase II carboxyl-terminal domain (CTD) is required to resume sequential transcription cycles. FCP1 (TFIIF-dependent CTD phosphatase 1) is the only known phosphatase targeting RNAP II CTD. Here we show that in Xenopus laevis cells, xFCP1 is a phosphoprotein. On the basis of biochemical fractionation and drug sensitivity, casein kinase 2 (CK2) is shown to be the major kinase involved in xFCP1 phosphorylation in X. laevis egg extracts. CK2 phosphorylates xFCP1 mainly at a cluster of serines centered on Ser(457). CK2-dependent phosphorylation enhances 4-fold the CTD phosphatase activity of FCP1 and its binding to the RAP74 subunit of general transcription factor TFIIF. These findings unravel a new mechanism regulating CTD phosphorylation and hence class II gene transcription.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138108     DOI: 10.1074/jbc.M205192200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  The C-terminal domain phosphatase and transcription elongation activities of FCP1 are regulated by phosphorylation.

Authors:  Erika M Friedl; William S Lane; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

2.  Phosphorylation by casein kinase 2 facilitates rRNA gene transcription by promoting dissociation of TIF-IA from elongating RNA polymerase I.

Authors:  Holger Bierhoff; Miroslav Dundr; Annemieke A Michels; Ingrid Grummt
Journal:  Mol Cell Biol       Date:  2008-06-16       Impact factor: 4.272

3.  Active bacterial modification of the host environment through RNA polymerase II inhibition.

Authors:  Inès Ambite; Nina A Filenko; Elisabed Zaldastanishvili; Daniel Sc Butler; Thi Hien Tran; Arunima Chaudhuri; Parisa Esmaeili; Shahram Ahmadi; Sanchari Paul; Björn Wullt; Johannes Putze; Swaine L Chen; Ulrich Dobrindt; Catharina Svanborg
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

4.  The functions of TFIIF during initiation and transcript elongation are differentially affected by phosphorylation by casein kinase 2.

Authors:  Andrea Újvári; Mahadeb Pal; Donal S Luse
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

5.  Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation.

Authors:  Janeen H Trembley; Sawako Tatsumi; Eiji Sakashita; Pascal Loyer; Clive A Slaughter; Hitoshi Suzuki; Hitoshi Endo; Vincent J Kidd; Akila Mayeda
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  Ssu72 is a phosphatase essential for transcription termination of snoRNAs and specific mRNAs in yeast.

Authors:  Carine Ganem; Frédéric Devaux; Claire Torchet; Claude Jacq; Sophie Quevillon-Cheruel; Gilles Labesse; Céline Facca; Gérard Faye
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

7.  The identification of putative RNA polymerase II C-terminal domain associated proteins in red and green algae.

Authors:  Chunlin Yang; Paul W Hager; John W Stiller
Journal:  Transcription       Date:  2014-12-10

8.  Bromodomain factor 1 (Bdf1) is phosphorylated by protein kinase CK2.

Authors:  Chika Sawa; Eduard Nedea; Nevan Krogan; Tadashi Wada; Hiroshi Handa; Jack Greenblatt; Stephen Buratowski
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

9.  Genetic interactions between an RNA polymerase II phosphatase and centromeric elements in Saccharomyces cerevisiae.

Authors:  E Pierstorff; C M Kane
Journal:  Mol Genet Genomics       Date:  2004-05-06       Impact factor: 3.291

10.  Halogenated imidazole derivatives block RNA polymerase II elongation along mitogen inducible genes.

Authors:  Michal Mikula; Karolina Hanusek; Agnieszka Paziewska; Artur Dzwonek; Tymon Rubel; Karol Bomsztyk; Jerzy Ostrowski
Journal:  BMC Mol Biol       Date:  2010-01-15       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.